Facioscapulohumeral Muscular Dystrophy Market In the year 2021, the total prevalent cases of FSHD were 78,790 in the 7MM which are expected to grow during the study period, i.e., 2019–2032. The Facioscapulohumeral Muscular Dystrophy therapeutics market is anticipated to grow in the coming years owing to the increasing prevalent population of FSHD patients in the […]
